C34H39N3O8 Cytidin, 5'-O-[bis(4-metoksyfenyl)fenylmetyl]-2'-O-(2-metoksyetyl)-5-metyl- (9CI, ACI)

Kanoniske SMIL O=C1N=C(N)C(=CN1C2OC(COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5) C(O)C2OCCCOC)C
Isomere SMIL C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C(=O)N=C(N)C(C)=C2 )(C3=CC=C(OC)C=C3)(C4=CC=C(OC)C=C4)C5=CC=CC=C5
InChI
InChI=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19-18-40-2)29(38)28(45-32) 21-44-34(23-8-6-5-7-9-23,24-10-14-26(4 1-3)15-11-24)25-12-16-27(42-4 )17-13-25/h5-17,20,28-30,32,38H,18-19,21H2,1-4H3,(H2,35,36,39)/t28-,29-,30-, 32-/m1/s1
InChI nøkkel
LYKTVJJXZQTNPK-PBAMLIMUSA-N
24 Andre navn for dette stoffet
5'-O-[bis(4-metoksyfenyl)fenylmetyl]-2'-O-(2-metoksyetyl)-5-metylcytidin (ACI);11: PN: US20030170636 SIDE: 17 påstått RNA;12: PN: US20030211606 SIDE: 18 hevdet R NA;12: PN: US20030212017 SIDE: 19 hevdet R NA;14: PN: US20040005569 PAG E: 21 hevdet R NA;15: PN: US20040005565 SIDE: 17-22 påstått RNA;15: PN: US20040005570 SIDE: 19 hevdet R NA;15: PN: U S20040006030 SIDE: 22 hevdet R NA;15: PN: US20040014048 SIDE: 19 hevdet R NA;16: PN: US20030171313 SIDE: 9 påstått RNA;16: PN: US20030198965 SIDE: 19 hevdet R NA;16: PN: US20040014047 SIDE: 19 hevdet R NA;16: PN: US20040014049 SIDE:

19 hevdet RNA;17: PN: US20040014051 SIDE: 21 hevdet R NA;17: PN: US20040014699 SIDE: 19 hevdet R NA;17: PN: W
O03106645 SIDE: 69 hevdet R NA;18: PN: US20040006029 SIDE: 22 hevdet R NA;2'-O-metoksyetyl-5'-O-dimetoksytrityl-5-metylcytidin;58: PN: US20030166592 SIDE: 15 hevdet R NA;5: PN: WO2005006958 SIDE: 61 påberopt R NA;7: PN: WO20050 07825 SIDE: 61 påberopt R NA;82: PN: US20040171566 SIDE: 18 hevdet R NA;89: PN: US20040005707 SIDE: 19 hevdet R NA;9: PN: WO03084478 SIDE: 56 hevdet R NA